Trial · NCT04531137
Conjugated Linoleic Acid on Body Weight and Body Fat Mass for 12 Weeks
NCT04531137, Not applicable, Unknown, Universitas Indonesia
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Conjugated Linoleic Acid on Body Weight and Body Fat Mass for 12 Weeks. Trials, record NCT04531137. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04531137
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Conjugated Linoleic Acid on Body Weight and Body Fat Mass for 12 Weeks
- NCT number
- NCT04531137
- Status
- Unknown
- Phases
- Not applicable
- Enrollment
- 84 participants, estimated
- Lead sponsor
- Universitas Indonesia
- Conditions
- Overweight and Obesity, Body Weight
- Interventions
- CLA-fortified milk powder, Placebo, Nutrition Counseling
- First posted
- 2020-08-28
- Last updated
- 2021-08-17
Source ClinicalTrials.gov
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change of body weight | Baseline (after signing the consent) week-0, week-4, week-8, and week-12 (endline) | to investigate the change of body weight before, during and after intervention. Using Seca® type 876 is calibrated scale to the nearest 0.1 kilogram. The lower body weight indicates better outcome |
| Primary | Change of body fat mass | Baseline (after signing the consent) week-0 and week-12 (endline) | to investigate the change of body fat mass before and after intervention. Using Dual-energy X-ray absorptiometry (DXA GE Lunar® Prodigy 64179). The lower body fat mass indicates better outcome |
| Primary | Change of body fat mass | Baseline (after signing the consent) week-0, week-4, week-8, and week-12 (endline) | to investigate the change of body fat mass before, during, and after intervention. Using Bod Pod (Cosmed®). The lower body fat mass indicates better outcome |
| Secondary | Change of Waist hip ratio | Baseline (after signing the consent) week-0, week-4, week-8, and week-12 (endline) | to investigate the change of waist hip ratio before, during, and after intervention. Waist hip ratio is obtained by dividing the waist circumference and hip circumference. Tape measurement (Seca® type 201) is calibrated scale to nearest 0.1 centimeter. The lower body fat mass indicates better outcome |
| Secondary | Change of Low Density Lipoprotein (LDL) | Baseline (after signing the consent) week-0 and week-12 (endline) | to investigate the change of low density lipoprotein (LDL) in miligram per deciliter before and after intervention. The lower change of LDL indicates the better outcome. Enzymatic method |
| Secondary | Change of High Density Lipoprotein (HDL) | Baseline (after signing the consent) week-0 and week-12 (endline) | to investigate the change of high density lipoprotein (HDL) in miligram per deciliter before and after intervention. The higher change of HDL indicates the better outcome. Enzymatic method |
| Secondary | Change of Total of Cholesterol | Baseline (after signing the consent) week-0 and week-12 (endline) | to investigate the change of total of cholesterol in miligram per deciliter before and after intervention. The lower change of total of cholesterol indicates the better outcome. Enzymatic method |
| Secondary | Change of Triglyceride | Baseline (after signing the consent) week-0 and week-12 (endline) | to investigate the change of triglyceride in miligram per deciliter before and after intervention. The lower change of triglyceride indicates the better outcome. Enzymatic method |
| Secondary | Dietary intake (semi quantitative food frequency questionnaire) | Baseline (after signing the consent) week-0, week-8 and week-12 (endline) | to investigate the dietary intake before, during, and after intervention using semi quantitative food frequency questionnaire. The higher number of dietary intake indicates the better outcome |
| Secondary | Dietary intake (24-hours recall) | Baseline (after signing the consent) week-0, week-8 and week-12 (endline) | to investigate the dietary intake before, during, and after intervention using 24-hours recall. The higher dietary intake indicates the better outcome |
1 to 10 of 13Source ClinicalTrials.gov
See all 13 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT04531137
GET https://conductscience.org/api/trials/v1/NCT04531137/registered